Research Projects Available
Dphil in cardiovascular science
DPhil in medical sciences opportunities will appear below:
MSc by Research in medical sciences opportunities will appear below:
Colleges
Websites
-
Sky news
Findings from the C-MORE - multiorgan MRI Study
-
BBC news
Findings from the C-MORE - multiorgan MRI Study
-
BBC world radio
Betty Raman presenting findings from the C-MORE study (8:20)
Betty Raman
MBBS DPhil FESC FRACP
Associate Professor of Cardiovascular Medicine
- NIHR South Central RRDN Cardiology Specialty Lead
- Hon. Consultant Cardiologist (Loc)
- Oxford Programme Director of BHF Doctoral Training Programme on Technology, Data and AI (Imperial-Oxford DTP)
- Wellcome Career Development Award Fellow
- RDM Cardiovascular Medicine EDI Champion
Prof Betty Raman is a senior honorary consultant cardiologist specialising in advanced cardiovascular imaging (CMR and cardiac CT) and inherited and cardiomyopathic heart disease. She leads a translational research programme in monogenic (e.g., HCM, DCM etc) and polygenic cardiac (hypertensive heart diseases, cardiometabolic etc.) diseases that bridge mechanistic discovery, clinical application, and innovation in drug development.
After completing her specialist cardiology training in Australia (FRACP), she joined the University of Oxford in 2015 to pursue a DPhil in hypertrophic cardiomyopathy, the leading cause of sudden cardiac death in young adults and athletes. Her doctoral work led to the development of a novel oxygen sensitive magnetic resonance method that detects myocardial hypoxia non-invasively and holds promise as an early biomarker of disease activity. This pioneering work has been recognised internationally through awards from the ESC, AHA, BSCMR, SCMR, and BCS.
Building on this foundation, she was awarded a British Heart Foundation Transition Fellowship (2020) and subsequently a Wellcome Career Development Award (2024) to advance a multidisciplinary research programme integrating imaging, genetics, energetics, and computational modelling. Her goal is to identify and validate early markers of disease progression in hypertrophic (e.g., HCM) and related cardiomyopathies, enabling more precise risk prediction and supporting evaluation of emerging therapies.
During the COVID 19 pandemic, she led the C-MORE study, a large multicentre initiative that combined MRI, cardiopulmonary exercise testing, and cognitive assessments to characterise the long term multi organ consequences of COVID 19. This work helped shape understanding of post-viral cardiovascular and systemic recovery.
Her current research focuses on:
Early stage disease detection and monitoring in cardiomyopathies using next generation CMR including BOLD, DTI, spectroscopy, and radiomics.
Mechanistic biomarkers to support early phase and adaptive clinical trials.
Cross organ interactions in cardiometabolic disease, integrating heart, brain, liver, and renal imaging.
As a senior academic leader, she collaborates widely across academia, the NHS, and industry to translate advanced imaging into clinical and commercial impact. She actively welcomes scientific collaborators, students, and industrial partners interested in biomarker discovery, imaging enabled trial design, and AI based modelling for cardiovascular disease.
Recent publications
Motion-Conditioned Multi-view Fusion for Myocardial Infarction Localization from Echocardiography
Chapter
Yang G. et al, (2027), 16885 LNCS, 445 - 455
Can Intravenous Cangrelor Protect the Myocardium in Infarction-related Cardiogenic Shock?
Journal article
Raman B. and Bohula EA., (2026), Circulation
Sputum and oral microbiota profiles are associated with long COVID severity and phenotype post-hospitalisation: a UK multicentre, prospective cohort study.
Journal article
Alferes de Lima Headley D. et al, (2026), Eur Respir J
Probable post-traumatic stress disorder following discharge from hospital with COVID-19: prospective cohort study.
Journal article
Anik E. et al, (2026), BJPsych Open, 12
Breathlessness catastrophising after COVID-19 involves both interoceptive and visceromotor connectivity
Preprint
Qiu L. et al, (2026)
Validation of the General Practice Physical Activity Questionnaire after severe COVID-19.
Journal article
Wang L. et al, (2026), ERJ Open Res, 12
Mapping organ fat distribution and body composition: towards precision profiling of cardiometabolic disease risk.
Journal article
Kway YM. et al, (2026), Eur Heart J
Recombinant shingles vaccination and the risk of cardiovascular events.
Journal article
Corsi-Zuelli F. et al, (2026), Nat Med
COVID-19 outcomes and persistent symptoms in patients with hypertrophic cardiomyopathy: association with pre-existing cardiovascular magnetic resonance phenotype.
Journal article
Singhal A. et al, (2026), Heart
Late Gadolinium Enhancement in Nonischemic Dilated Cardiomyopathy.
Journal article
Raman B. and Prasad SK., (2026), Circulation, 154, 512 - 516
HFpEF and MASLD: converging mechanisms and clinical implications.
Journal article
Capone F. et al, (2026), Nat Rev Cardiol, 23, 584 - 608
Cardiac morphology and flow dynamics in children born to hypertensive pregnancies.
Journal article
Sattwika PD. et al, (2026), Eur Heart J Imaging Methods Pract, 4
Pictorial review: a step-by-step guide to coronary CT angiography with photon-counting detector CT.
Journal article
Xie C. et al, (2026), Br J Radiol, 99, 1518 - 1528
Multi-organ structural and functional deficits in association with long COVID: a population-based case-control study.
Journal article
Fernández-Sanlés A. et al, (2026), EClinicalMedicine, 98
Trientine for hypertrophic cardiomyopathy: a phase 2 trial.
Journal article
Farrant JP. et al, (2026), Eur Heart J
Investigating prognostic classifications of preexisting multiple long-term conditions for health outcomes 1 year after COVID-19 hospitalization: A UK prospective observational study.
Journal article
Gardiner LE. et al, (2026), Int J Infect Dis, 168
Non-invasive pressure-volume loop analysis in left ventricular load manipulation.
Journal article
Pola K. et al, (2026), Clin Physiol Funct Imaging, 46
Digital twin reconstruction of ventricular repolarisation identifies regional causes of T-wave abnormalities in hypertrophic cardiomyopathy
Preprint
Coleman JA. et al, (2026)
A systematic review of explainable artificial intelligence and cardiac electrophysiological models addressing sports-related sudden cardiac death and arrest in adolescents and young adults.
Journal article
Vanegas Müller E. et al, (2026), NPJ Digit Med, 9
Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy: The NHLBI HCM Registry.
Journal article
HCMR Investigators . et al, (2026), JAMA, 335, 1959 - 1969
Biobank-Scale Plasma Proteomics Identifies Novel Biomarkers in Hypertrophic Cardiomyopathy.
Journal article
Chan JH. et al, (2026), Circ Genom Precis Med, 19
Consortium-Based Patient and Public Involvement and Engagement for Long COVID Research: A Pirit-Focused Impact Evaluation of the PHOSP-COVID Study.
Journal article
Houchen-Wolloff L. et al, (2026), Health Expect, 29
Evaluating Acute Ischemic Myocardial Injury With Photon-Counting Computed Tomography.
Journal article
Kotronias RA. et al, (2026), JACC Cardiovasc Imaging, 19, 284 - 287
Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury.
Journal article
Stewart I. et al, (2026), EBioMedicine, 124
Left Atrial Reservoir Strain Predicts Atrial Fibrillation in Hypertrophic Cardiomyopathy: Insights from the NHLBI HCM Registry.
Journal article
Beyhoff N. et al, (2026), JACC Cardiovasc Imaging, 19, 133 - 135
Comparison of cardiac diffusion MRI using multiple prospective respiratory motion correction techniques.
Journal article
Jermy S. et al, (2026), Magn Reson Med, 95, 442 - 456
Human genetics implicate thromboembolism in the pathogenesis of long COVID in individuals of European ancestry.
Journal article
Schuermans A. et al, (2025), Nat Cardiovasc Res, 4, 1662 - 1676
A Review of Multimodality Imaging in Hypertrophic Cardiomyopathy: Diagnosis, Risk Stratification, and Therapeutic Guidance.
Journal article
Gandhi R. et al, (2025), Radiol Cardiothorac Imaging, 7
Computational modelling of myocardial metabolism in patients with advanced heart failure.
Journal article
Beyhoff N. et al, (2025), Eur J Heart Fail, 27, 3411 - 3422
Sleep apnea at the frontier- an integrated multidisciplinary functional framework.
Journal article
Beache GM. et al, (2025), Sleep Med Rev, 84
The safety, physiological response and repeatability of the incremental shuttle walk test in survivors of COVID-19.
Journal article
Baldwin MM. et al, (2025), ERJ Open Res, 11
Brain and muscle chemistry in myalgic encephalitis/chronic fatigue syndrome (ME/CFS) and long COVID: a 7T magnetic resonance spectroscopy study.
Journal article
Godlewska BR. et al, (2025), Mol Psychiatry, 30, 5215 - 5226
Subclinical Postpartum Renal Structure After Hypertensive Pregnancy Disorders.
Journal article
Cutler HR. et al, (2025), Hypertension, 82, 1948 - 1958
Clinical and cost-effectiveness of diverse posthospitalisation pathways for COVID-19: a UK evaluation using the PHOSP-COVID cohort.
Journal article
Briggs AH. et al, (2025), BMJ Open Respir Res, 12
Modulating myocardial metabolism in preclinical hypertrophic cardiomyopathy pathogenic variant carriers: a window of opportunity or wishful thinking?
Journal article
Raman B. and Brociek E., (2025), Cardiovasc Res, 121, 1806 - 1808
Causal relevance of clonal haematopoiesis with cardiac disease and adverse remodelling: a Mendelian randomisation study.
Journal article
Morley AP. et al, (2025), Open Heart, 12
Sex Differences in the Genetic Causes of Dilated Cardiomyopathy.
Journal article
Mangino M. et al, (2025), J Am Coll Cardiol, 86, 400 - 403
Correction to: Multiorgan Imaging for Interorgan Crosstalk in Cardiometabolic Diseases.
Journal article
Devesa A. et al, (2025), Circ Res, 137
Cohort profile: characterisation, determinants, mechanisms and consequences of the long-term effects of COVID-19 - providing the evidence base for health care services (CONVALESCENCE) in the UK.
Journal article
Jamieson A. et al, (2025), BMJ Open, 15
Could CT radiomics be the new frontier for myocardial tissue characterization in cardiomyopathies?
Journal article
Raman B. and Clarke N., (2025), Eur Heart J Cardiovasc Imaging, 26, 1049 - 1050
Multiorgan Imaging for Interorgan Crosstalk in Cardiometabolic Diseases.
Journal article
Devesa A. et al, (2025), Circ Res, 136, 1454 - 1475
Post-Hospitalisation COVID-19 Rehabilitation (PHOSP-R): a randomised controlled trial of exercise-based rehabilitation.
Journal article
Daynes E. et al, (2025), Eur Respir J, 65
Considerations for drug trials in hypertrophic cardiomyopathy.
Journal article
Farrant JP. et al, (2025), ESC Heart Fail, 12, 1095 - 1112
Assessing the impact of COmorbidities and Sociodemographic factors on Multiorgan Injury following COVID-19: rationale and protocol design of COSMIC, a UK multicentre observational study of COVID-negative controls.
Journal article
Shergill S. et al, (2025), BMJ Open, 15
Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy.
Journal article
Tadros R. et al, (2025), Nat Genet, 57, 530 - 538
Demographic-Based Personalized Left Ventricular Hypertrophy Thresholds for Hypertrophic Cardiomyopathy Diagnosis.
Journal article
Shiwani H. et al, (2025), J Am Coll Cardiol, 85, 685 - 695
Incidence of diabetes mellitus following hospitalisation for COVID-19 in the United Kingdom: A prospective observational study.
Journal article
Tyrer F. et al, (2025), Diabetes Obes Metab, 27, 767 - 776
Multiparametric cardiovascular magnetic resonance evaluation of myocardial perfusion, oxygenation, and energetics in hypertrophic cardiomyopathy following cardiac myosin inhibitor therapy.
Journal article
Finnigan LEM. et al, (2025), Eur Heart J Cardiovasc Imaging, 26
Myocardial disarray and fibrosis across hypertrophic cardiomyopathy stages associate with ECG markers of arrhythmic risk.
Journal article
Ashkir Z. et al, (2025), Eur Heart J Cardiovasc Imaging, 26, 218 - 228